Development from idea to commercialization
The scientific approach
We utilize a Quality by Design (QbD) framework to ensure every formulation is robust, stable, and scalable. Our expertise lies in navigatingthe balance between chemical stability, physical integrity, and biological performance.
Core capabilities
Immediate-release (IR) systems:
Development of tablets and capsules focusing on biocomplexity and stability for challenging molecules.
Modified-release technologies:
- Delayed release (DR): Enteric-coated systems for gastric protection or targeted intestinal release.
- Extended release (ER): Matrix and reservoir systems engineered for consistent therapeutic levels over 12-24 hours.
- Sustained release (SR): Precision-timed profiles to improve compliance and reduce side effects.
Difficult-to-formulate molecules:
Expertise in BCS class II and IV (poor solubility), complex polymorphic behaviors,and moisture/light-sensitive compounds.